Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, 2028, South Africa.
Stem Cell Rev Rep. 2024 Feb;20(2):509-523. doi: 10.1007/s12015-023-10655-6. Epub 2023 Dec 14.
Regenerative medicine has developed as a promising discipline that utilizes stem cells to address limitations in traditional therapies, using innovative techniques to restore and repair damaged organs and tissues. One such technique is the generation of three-dimensional (3D) organoids in stem cell therapy. Organoids are 3D constructs that resemble specific organs' structural and functional characteristics and are generated from stem cells or tissue-specific progenitor cells. The use of 3D organoids is advantageous in comparison to traditional two-dimensional (2D) cell culture by bridging the gap between in vivo and in vitro research. This review aims to provide an overview of the advancements made towards regenerative medicine using stem cells to generate organoids, explore the techniques used in generating 3D organoids and their applications and finally elucidate the challenges and future directions in regenerative medicine using 3D organoids.
再生医学作为一门有前途的学科得到了发展,它利用干细胞利用创新技术来解决传统疗法的局限性,从而恢复和修复受损的器官和组织。干细胞治疗中生成三维(3D)类器官就是一种这样的技术。类器官是一种 3D 结构,具有特定器官的结构和功能特征,并由干细胞或组织特异性祖细胞生成。与传统的二维(2D)细胞培养相比,3D 类器官的使用具有优势,因为它弥补了体内和体外研究之间的差距。本综述旨在概述使用干细胞生成类器官的再生医学进展,探讨生成 3D 类器官的技术及其应用,并最终阐明使用 3D 类器官进行再生医学的挑战和未来方向。
Stem Cell Rev Rep. 2024-2
Tissue Eng Regen Med. 2024-12
Development. 2015-9-15
Tissue Eng Part A. 2024-6
J Mol Med (Berl). 2017-7
Crit Rev Biotechnol. 2022-5
Methods Mol Biol. 2023
Adv Exp Med Biol. 2018
Regen Eng Transl Med. 2023
Stem Cell Rev Rep. 2025-9-3
Hum Reprod Update. 2025-3-1
Int J Mol Sci. 2024-7-16
Smart Med. 2022-12-27
Biophys Rev (Melville). 2021-6-17
Ann Hepatobiliary Pancreat Surg. 2023-11-30
Cancer Cell Int. 2023-6-19
Nat Rev Methods Primers. 2022
MedComm (2020). 2023-5-17
Signal Transduct Target Ther. 2023-3-20
Int J Mol Sci. 2023-2-16